Who is eligible to apply for EMCURE PHARMACEUTICALS L rights issue?

Existing shareholders of EMCURE PHARMACEUTICALS L as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.

How can existing shareholders apply for EMCURE PHARMACEUTICALS L rights issue?

Shareholders can apply for EMCURE PHARMACEUTICALS L rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.

Is the rights issue of EMCURE PHARMACEUTICALS L mandatory for existing shareholders?

No! Participation in EMCURE PHARMACEUTICALS L rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.

Has EMCURE PHARMACEUTICALS L announced any rights issues in the past?

No, EMCURE PHARMACEUTICALS L hasn’t had any right issues as of {{current_date}} in last 2023-2025

What was the last rights issue price and ratio for EMCURE PHARMACEUTICALS L?

No, EMCURE PHARMACEUTICALS L hasn’t had any right issues as of {{current_date}} in last 2023-2025

Emcure Pharmaceuticals L Rights Issue

Emcure Pharmaceuticals L has not split the face value of the share since 29 Aug, 2023

₹1866.00₹1866.00+1.00 (0.05%)

Last updated on 31 Oct, 2026 | 10:45 IST

Dividends
Splits
Bonus
Rights